Direct photodegradation of carbamazepine followed by micellar electrokinetic chromatography and mass spectrometry

被引:111
作者
Calisto, Vania [1 ,2 ]
Domingues, M. Rosario M. [3 ]
Erny, Guillaume L. [1 ,2 ]
Esteves, Valdemar I. [1 ,2 ]
机构
[1] Univ Aveiro, Dept Chem, P-3810193 Aveiro, Portugal
[2] Univ Aveiro, CESAM Ctr Environm & Marine Studies, P-3810193 Aveiro, Portugal
[3] Univ Aveiro, Mass Spectrometry Ctr, Dept Chem, P-3810193 Aveiro, Portugal
关键词
Pharmaceuticals; Environment; Persistence; Capillary electrophoresis; Quantum yield; Oxygen; WASTE-WATER TREATMENT; SEWAGE-TREATMENT PLANTS; AQUATIC ENVIRONMENT; HYDRATED ELECTRONS; COATED CAPILLARIES; AROMATIC-COMPOUNDS; DRINKING-WATER; SURFACE WATERS; PHARMACEUTICALS; FATE;
D O I
10.1016/j.watres.2010.10.037
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Carbamazepine, a widely consumed psychotropic pharmaceutical, is one of the most commonly detected drugs in the environment. To better assess the environmental persistence of carbamazepine in aqueous matrices, the effect of pH and dissolved oxygen on the direct photodegradation rate of this pharmaceutical was evaluated in this study, using simulated solar irradiation. In order to follow the degradation and the emergence of photoproducts, a micellar electrokinetic chromatography based method was developed, consisting on the use of a dynamically coated capillary column. The developed methodology showed good repeatability and efficiency in the separation of carbamazepine and photoirradiation products. Also, seven photodegradation products were identified by electrospray mass spectrometry (ESI-MS), including the known carcinogenic acridine that was produced under all the pH and oxygenation levels studied and one newly identified photoproduct. This paper gives new insights into the role of dissolved oxygen on the photodegradation rate of carbamazepine. The results indicate that acidic pH, combined with the absence of dissolved oxygen in the aqueous matrix, results in very high direct photodegradation rates. At basic pH, dissolved oxygen does not interfere with the process and very low rates were observed. At environmentally relevant conditions, carbamazepine was shown to persist in the environment from 4.5 to 25 days. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1095 / 1104
页数:10
相关论文
共 44 条
[1]   REACTIVITY OF AROMATIC COMPOUNDS TOWARD HYDRATED ELECTRONS [J].
ANBAR, M ;
HART, EJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1964, 86 (24) :5633-&
[2]   Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment [J].
Andreozzi, R ;
Marotta, R ;
Paxeus, N .
CHEMOSPHERE, 2003, 50 (10) :1319-1330
[3]   Carbamazepine in water: persistence in the environment, ozonation treatment and preliminary assessment on algal toxicity [J].
Andreozzi, R ;
Marotta, R ;
Pinto, G ;
Pollio, A .
WATER RESEARCH, 2002, 36 (11) :2869-2877
[4]  
Arnold W.A., 2007, ANAL FATE REMOVAL PH
[5]   Monitoring carbamazepine in surface and wastewaters by an immunoassay based on a monoclonal antibody [J].
Bahlmann, Arnold ;
Weller, Michael G. ;
Panne, Ulrich ;
Schneider, Rudolf J. .
ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2009, 395 (06) :1809-1820
[6]   Occurrence and fate of pharmaceutically active compounds in the environment, a case study:: Hoje River in Sweden [J].
Bendz, D ;
Paxéus, NA ;
Ginn, TR ;
Loge, FJ .
JOURNAL OF HAZARDOUS MATERIALS, 2005, 122 (03) :195-204
[7]   Photodegradation of pharmaceuticals in the aquatic environment: A review [J].
Boreen, AL ;
Arnold, WA ;
McNeill, K .
AQUATIC SCIENCES, 2003, 65 (04) :320-341
[8]   Effects of 25 pharmaceutical compounds to Lemna gibba using a seven-day static-renewal test [J].
Brain, RA ;
Johnson, DJ ;
Richards, SM ;
Sanderson, H ;
Sibley, PK ;
Solomon, KR .
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2004, 23 (02) :371-382
[9]   Waterborne and sediment toxicity of fluoxetine to select organisms [J].
Brooks, BW ;
Turner, PK ;
Stanley, JK ;
Weston, JJ ;
Glidewell, EA ;
Foran, CM ;
Slattery, M ;
La Point, TW ;
Huggett, DB .
CHEMOSPHERE, 2003, 52 (01) :135-142
[10]   Aquatic ecotoxicology of fluoxetine [J].
Brooks, BW ;
Foran, CM ;
Richards, SM ;
Weston, J ;
Turner, PK ;
Stanley, JK ;
Solomon, KR ;
Slattery, M ;
La Point, TW .
TOXICOLOGY LETTERS, 2003, 142 (03) :169-183